MGMT and metastatic melanoma: We observed an inverse relationship between MGMT expression and clinical response to DTIC-based chemotherapy in patients with metastatic melanoma (P=0.05), indicating that MGMT is a factor that contributes to drug resistance against DTIC-based chemotherapy in melanoma.